Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunogen (IMGN)
NASDAQ:IMGN
ImmunoGen (IMGN) Financial Statements
1,265 Followers
ImmunoGen Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 113.42M | $ 77.37M | $ 800.00K | $ 1.10M | $ 15.38M |
| Gross Profit | $ 113.42M | $ 83.15M | $ 800.00K | $ 1.10M | - |
| EBIT | $ 32.08M | $ -3.37M | $ -41.01M | $ -63.14M | $ -76.89M |
| EBITDA | - | $ -3.95M | $ -41.55M | - | $ -76.46M |
| Net Income Common Stockholders | $ 38.65M | $ -4.25M | $ -41.01M | $ -59.01M | $ -77.75M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 605.50M | $ 572.00M | $ 201.20M | $ 275.10M | $ 309.51M |
| Total Assets | $ 822.10M | $ 714.33M | $ 288.35M | $ 348.87M | $ 358.80M |
| Total Debt | $ 84.33M | $ 85.21M | $ 14.26M | $ 15.24M | $ 16.20M |
| Net Debt | $ -521.17M | $ -486.79M | $ -186.94M | $ -259.86M | $ -293.31M |
| Total Liabilities | $ 260.50M | $ 223.49M | $ 166.43M | $ 343.01M | $ 180.79M |
| Stockholders Equity | $ 561.60M | $ 490.84M | $ 121.92M | $ 149.90M | $ 178.01M |
| Cash Flow | - | ||||
| Free Cash Flow | - | $ -68.09M | $ -73.93M | $ -61.00M | $ -64.81M |
| Operating Cash Flow | $ 2.77M | $ -68.01M | $ -73.72M | $ -60.75M | $ -64.21M |
| Investing Cash Flow | $ -1.35M | $ 1.16M | $ -209.00K | $ 330.00K | $ -602.00K |
| Financing Cash Flow | $ 32.13M | $ 437.56M | $ 39.00K | $ 26.07M | $ 449.00K |
ImmunoGen Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.